NEKTAR THERAPEUTICS Logo

NEKTAR THERAPEUTICS

Biopharma firm developing medicines for autoimmune and inflammatory conditions.

NKTR | US

Overview

Corporate Details

ISIN(s):
US6402681083
LEI:
Country:
United States of America
Address:
455 MISSION BAY BOULEVARD SOUTH, 94158 SAN FRANCISCO

Description

Nektar Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel medicines for autoimmune and inflammatory conditions. The company's research centers on modulating the immune system to resolve imbalances and restore homeostasis. By leveraging its expertise in immune pathways, Nektar aims to develop first-in-class, disease-modifying therapies that address the root causes of immune dysfunction. Its pipeline includes investigational candidates such as rezpegaldesleukin, a therapy designed to stimulate regulatory T cells for the treatment of conditions like severe alopecia areata.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 02:30
4
English 8.5 KB
2025-11-26 02:29
4
English 8.6 KB
2025-11-26 02:28
4
English 8.5 KB
2025-11-25 21:35 English 7.4 KB
2025-11-25 21:32 English 7.1 KB
2025-11-25 21:28 English 7.3 KB
2025-11-21 22:06
CURRENT REPORT
English 65.2 KB
2025-11-14 22:31 English 9.3 KB
2025-11-14 22:23 English 9.5 KB
2025-11-13 23:45 English 11.0 KB
2025-11-12 22:17
REGISTRATION STATEMENT
English 143.7 KB
2025-11-12 22:09
424B5
English 162.4 KB
2025-11-12 22:06
S-3ASR
English 352.5 KB
2025-11-10 12:31
CURRENT REPORT
English 107.0 KB
2025-11-06 23:58
10-Q
English 1.8 MB

Automate Your Workflow. Get a real-time feed of all NEKTAR THERAPEUTICS filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEKTAR THERAPEUTICS

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEKTAR THERAPEUTICS via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.